
1. Vaccine. 2021 Nov 26;39(48):6969-6971. doi: 10.1016/j.vaccine.2021.10.069. Epub
2021 Nov 1.

Multicomponent vaccines to fight SARS-CoV-2 variants of concern.

Cassone A(1), Cauda R(2).

Author information: 
(1)Polo d'innovazione della genomica, genetica e biologia, c/o Toscana Life
Sciences, Strada del Petriccio e Belriguardo, 53100 Siena, Italy. Electronic
address: a.cassone@pologgb.com.
(2)Dipartimento di Sicurezza e Bioetica, Universit√† Cattolica del Sacro Cuore,
Rome, Italy. Electronic address: roberto.cauda@unicatt.it.

DOI: 10.1016/j.vaccine.2021.10.069 
PMCID: PMC8557988
PMID: 34743927  [Indexed for MEDLINE]

Conflict of interest statement: Declaration of Competing Interest The authors
declare that they have no known competing financial interests or personal
relationships that could have appeared to influence the work reported in this
paper.

